GlassScriptPhysician profile
Chase C Wagner
NPI 1528510930
$4,245.93
in general payments reported to CMS, 2019-2025
31 companies · $1,077 in 2025
The $1,077 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $785 · 2023: $1,117 · 2024: $1,267 · 2025: $1,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,460.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $716.93 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $616.44 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $455.71 | 2022-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.63 | 2022-2025 | Jardiance |
| Boston Scientific Corporation | $249.60 | 2022-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $236.25 | 2022-2024 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $211.42 | 2022-2023 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $195.36 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $161.02 | 2022-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals International, Plc | $127.70 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $124.07 | 2022-2024 | Nexletol |
| Novo Nordisk INC | $115.18 | 2022-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $89.58 | 2023-2025 | Farxiga, Wainua |
| Alnylam Pharmaceuticals INC. | $75.80 | 2024-2025 | Amvuttra |
| Irhythm Technologies, INC. | $71.98 | 2022-2024 | Zio Xt Patch, Zio Monitor |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $71.72 | 2024 | Inspire |
| Cvrx, INC. | $62.36 | 2023-2025 | Barostim Neo System |
| Baxter Healthcare | $61.89 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $50.44 | 2023-2024 | (Ck4) Mcot |
| Abiomed | $41.30 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.95 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $30.99 | 2024 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $28.49 | 2025 | |
| Genzyme Corporation | $24.71 | 2025 | |
| Medtronic, INC. | $24.41 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $24.06 | 2025 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $23.19 | 2024 | |
| Impulse Dynamics (USA) INC. | $22.29 | 2025 | Optimizer |
| Abbott Laboratories | $20.15 | 2023 | Mitraclip |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.31 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.